Emergenet BioSolutions

FDA accepts Emergent BioSolutions’ anthrax vaccine candidate for review
Pharmaceutical Business Review
Mon, 06/27/22 - 10:16 am
Emergenet BioSolutions
vaccines
anthrax
FDA
AV7909